Overcoming nonviral gene delivery barriers: perspective and future. - Wikidata - awgldk - TriplyDB

Overcoming nonviral gene delivery barriers: perspective and future.

Overcoming nonviral gene delivery barriers: perspective and future.

http://www.wikidata.org/entity/Q39339350

about

Delivery of oligonucleotides with lipid nanoparticles Influence of molecular weight upon mannosylated bio-synthetic hybrids for targeted antigen presenting cell gene delivery Polyion complex (PIC) particles: Preparation and biomedical applications Structures of malonic acid diamide/phospholipid composites and their lipoplexes.Lipophosphoramidate-based bipolar amphiphiles: their syntheses and transfection properties.Efficient gene delivery system mediated by cis-aconitate-modified chitosan-g-stearic acid micelles.Theranostic nanoparticles based on bioreducible polyethylenimine-coated iron oxide for reduction-responsive gene delivery and magnetic resonance imaging Hybrid biosynthetic gene therapy vector development and dual engineering capacity.Non viral vectors in gene therapy- an overview.Stability and toxicity of empty or gene-loaded lipopolysaccharide-amine nanopolymersomes Mannosylated poly(beta-amino esters) for targeted antigen presenting cell immune modulation.Synthesis of bifunctional molecules containing [12]aneN3 and coumarin moieties as effective DNA condensation agents and new non-viral gene vectors.Modulation of Gene Expression by Polymer Nanocapsule Delivery of DNA Cassettes Encoding Small RNAs.Identification of possible cytotoxicity mechanism of polyethylenimine by proteomics analysis.Delivery of DNAzyme targeting aurora kinase A to inhibit the proliferation and migration of human prostate cancer.Cyclodextrin-based facial amphiphiles: assessing the impact of the hydrophilic-lipophilic balance in the self-assembly, DNA complexation and gene delivery capabilities.The Comparative Utility of Viromer RED and Lipofectamine for Transient Gene Introduction into Glial Cells.Glucocorticoid Cell Priming Enhances Transfection Outcomes in Adult Human Mesenchymal Stem Cells.Critical Length of PEG Grafts on lPEI/DNA Nanoparticles for Efficient in Vivo Delivery.In situ pneumococcal vaccine production and delivery through a hybrid biological-biomaterial vector.In vivo delivery of miRNAs for cancer therapy: challenges and strategies.Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments.All-Atom MD Predicts Magnesium-Induced Hairpin in Chemically Perturbed RNA Analog of F10 Therapeutic.Overcoming Gene-Delivery Hurdles: Physiological Considerations for Nonviral Vectors.Involvement of a Rac1-Dependent Macropinocytosis Pathway in Plasmid DNA Delivery by Electrotransfection.A naphthalimide-based [12]aneN3 compound as an effective and real-time fluorescence tracking non-viral gene vector.Gene expression of ternary complexes through the compaction of nanofiber-polyplexes by mixing with lipofectamine.α-Tocopherol derived lipid dimers as efficient gene transfection agents. Mechanistic insights into lipoplex internalization and therapeutic induction of apoptotic activity.Structure-Function Correlations of Poly(Amido Amine)s for Gene Delivery.Folate-targeted liposome encapsulating chitosan/oligonucleotide polyplexes for tumor targeting.Synthesis and gene transfection activity of cyclen-based cationic lipids with asymmetric acyl-cholesteryl hydrophobic tails.Biomaterial-Guided Gene Delivery for Musculoskeletal Tissue Repair.Barriers to Liposomal Gene Delivery: from Application Site to the Target.Oral nucleic acid therapy using multicompartmental delivery systems.Optogenetic Modulation of Intracellular Signalling and Transcription: Focus on Neuronal Plasticity.Zn(II)-dipicolylamine-based metallo-lipids as novel non-viral gene vectors.A Triple-Fluorophore-Labeled Nucleic Acid pH Nanosensor to Investigate Non-viral Gene Delivery.Functional lipids based on [12]aneN3 and naphthalimide as efficient non-viral gene vectors.Amino acid-based cationic lipids with α-tocopherol hydrophobic tail for efficient gene delivery.PGMA-based gene carriers with lipid molecules.

P2860

Q27024646-DE3A7C50-9D99-4DCF-8B19-13EFEA5F9F1F Q28817429-2EC15332-5B95-492C-84EB-0DB80CC91DA9 Q28831355-DC5390ED-B527-4DCE-A14E-B9179B01744C Q30314344-D21B2E86-4655-4BB2-9539-C9CC490837ED Q31044188-165B758A-53B0-4375-99C6-9DC273F0A349 Q33800625-E829A623-6034-4A53-B4C8-BED67F2E1223 Q33906003-6192CA18-3D20-4371-A00A-DA896D2B8879 Q34120110-D72E8061-7D53-4803-BCAA-CB0DF3C6962B Q34668309-C799364E-3508-4C90-9BC6-502192056207 Q34982400-7B39800A-C1CF-406C-8431-E6B8BDE09748 Q35469783-2D1E4178-7F08-4A07-99A5-69B83BAAB324 Q35577500-089FBEF3-5D22-4E33-8DE8-259C2B0E4550 Q35650064-FA8AC69A-B016-4B79-B0A0-D53D7F77A80E Q35680941-0E885B10-E80B-4D3A-858A-72DCCAC659DC Q35794644-031FE5CA-8483-4C9E-8D4A-E879BDB33E71 Q36158967-F7BD01D2-2B75-4E94-A4D4-0F320E29F22B Q36204154-AF55BC83-720E-40AF-BB08-295225DD2450 Q36756853-C6DCA6FE-C727-4C0D-AFED-EA2820E9C2C9 Q36793350-442DE520-E150-4DD1-ADF3-C733612ACF5E Q37088578-FF8EDFAA-DC4D-40A3-BBD6-740C7E205C41 Q37228217-FEA82A4E-F002-4859-89BD-CE563A24B8CC Q38247299-2F7350D1-30E0-4CF7-A483-EBB78AECC6F7 Q38660825-71230139-114B-437F-AB36-F677E177FD08 Q38685860-2B26AB0D-114B-49C6-9C07-38239E61D2DC Q38719094-AD38A827-0C16-4228-B1F3-76F73AF2759A Q38830347-FECD23FE-71DF-4EE7-B02E-D88E00A4E811 Q38848177-7C1DB918-DE5E-465A-B9DE-8EC90C71BDD7 Q38922635-E6C1D193-63D0-475A-B8B2-E8D70E9A4B43 Q38966744-010C892B-EC84-4DEF-837A-F849ED2B991B Q38993006-4ECD7865-0C6D-4D04-A813-C7E5FD3B12A4 Q39002262-E5FC81F9-74B3-42B5-ADB5-58BE7DA1F32C Q39122705-E3469532-1F5F-4EAE-9E90-9B223512A995 Q39147224-80598B7C-86E5-4244-A69E-4BEB0C71025C Q39330117-A073DC07-F13B-4E09-8552-FE97E41C6A02 Q39349827-48AD8003-F14B-4625-9349-8F7655B61881 Q40199835-9E30E968-E08E-4D0A-AFAF-27AD4A2038DE Q40212198-DAE322EC-86FD-4127-BCB8-57B8EEB15B1C Q40713414-1667E106-3865-4EF0-929A-62C1BBD95802 Q40940645-2D92B65C-3165-44AB-8CA7-219B17FA1DE2 Q45855898-9E2F3B92-FF55-49B0-92F4-463E385EE64C

P2860

Overcoming nonviral gene delivery barriers: perspective and future.

http://www.wikidata.org/entity/Q39339350

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Overcoming nonviral gene delivery barriers: perspective and future.

@en

Overcoming nonviral gene delivery barriers: perspective and future.

@nl

type

label

Overcoming nonviral gene delivery barriers: perspective and future.

@en

Overcoming nonviral gene delivery barriers: perspective and future.

@nl

prefLabel

Overcoming nonviral gene delivery barriers: perspective and future.

@en

Overcoming nonviral gene delivery barriers: perspective and future.

@nl

P1433

Q39339350-95DB2793-127C-43CF-9922-26B386492ED5

P1476

Q39339350-2C1D476E-09FC-438D-85B2-7ACEA3D772DC

P2093

Q39339350-4DAEFDCF-5942-426D-AC56-C18631D851CB

Q39339350-4E8E686A-4B26-4132-86EC-1DE75260E1BB

Q39339350-621C76A2-7456-46C6-BB63-C99691624655

Q39339350-AECCBC8C-1BE4-415D-AAB8-93D37C5816F9

Q39339350-F3733C1E-F321-4B38-927B-3A83761AD486

P2860

Q39339350-03C41810-7C3E-4A5B-9BB3-614333EBB285

Q39339350-06E47740-2353-4BBA-AF74-64F8CAAFBBCA

Q39339350-07F20975-F4FA-4A16-941B-C15CACBE6D4C

Q39339350-0AC96D70-C076-44F6-9203-DF01527AE7B8

Q39339350-0AEA9A3B-FB35-474A-85C1-3748570DF450

Q39339350-0F29376E-3074-4AC1-BEAD-EA7A06762598

Q39339350-11DBD128-82BE-44AB-B697-E92FEF38B253

Q39339350-143CF07F-BA52-4BE7-911C-7750779EA521

Q39339350-14D63A0A-9822-42D1-8305-3FBCA926C9E2

Q39339350-16A09501-B58D-4424-BF87-825DA32337AF

P304

Q39339350-9FA6AAAD-6236-4817-B8D0-81CB9A746ED1

P31

Q39339350-2FBC620A-AC54-49C7-BD95-7974AE1CBA36

P356

Q39339350-D29AECE4-553E-487E-8FD5-2CC11930AE92

P407

Q39339350-4E1CA94A-5156-4E3C-8772-8026C26DADC7

P433

Q39339350-45F410DB-E418-4DBB-8F76-303524EF1AFB

P478

Q39339350-38D82A54-610D-46AF-A7A1-AF6EB9A5B669

P577

Q39339350-AEF1196D-FD48-43F5-B5F6-513653C2378C

P5875

Q39339350-9D1B7365-8F1A-4599-9618-39AE10E92BE4

P698

Q39339350-A35DE3B3-7F4E-4068-8796-CCD9EA73CC01

P932

Q39339350-1672C85C-FC25-479E-B2B3-83DEA77A23F0

P356

P1433

Molecular Pharmaceutics

P1476

Overcoming nonviral gene delivery barriers: perspective and future.

@en

P2093

Anitha Ravikrishnan

http://www.w3.org/2001/XMLSchema#string

Blaine A Pfeifer

http://www.w3.org/2001/XMLSchema#string

Charles H Jones

http://www.w3.org/2001/XMLSchema#string

Chih-Kuang Chen

http://www.w3.org/2001/XMLSchema#string

Snehal Rane

http://www.w3.org/2001/XMLSchema#string

P2860

Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

Viral vectors: a look back and ahead on gene transfer technology

Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes

Purified Argonaute2 and an siRNA form recombinant human RISC

Challenges and strategies: the immune responses in gene therapy

Nucleocytoplasmic transport

Human RISC couples microRNA biogenesis and posttranscriptional gene silencing

Achieving targeted and quantifiable alteration of mRNA splicing with Morpholino oligos

A robust system for production of minicircle DNA vectors

P304

4082-4098

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/MP400467X

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257460859

http://www.w3.org/2001/XMLSchema#string

P698

24093932

http://www.w3.org/2001/XMLSchema#string

P932

5232591

http://www.w3.org/2001/XMLSchema#string